ChiCTR2100049025 版本V1.0 版本创建时间2021/10/27 20:29:19 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2100049025 

最近更新日期:

Date of Last Refreshed on:

2021-07-19 23:51:58 

注册时间:

Date of Registration:

2021-07-19 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

昼夜节律对成人喉罩置入时七氟烷临床效果影响的观察研究

Public title:

An observation study of the effect of circadian rhythm on the clinical effect of sevoflurane during laryngeal mask insertion in adults

注册题目简写:

昼夜节律对成人喉罩置入时七氟烷临床效果影响的观察研究

English Acronym:

研究课题的正式科学名称:

昼夜节律对成人喉罩置入时七氟烷临床效果影响的观察研究

Scientific title:

An observation study of the effect of circadian rhythm on the clinical effect of sevoflurane during laryngeal mask insertion in adults

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

周银红 

研究负责人:

陈玉培 

Applicant:

Yinhong Zhou 

Study leader:

Yupei Chen 

申请注册联系人电话:

Applicant telephone:

15073471062

研究负责人电话:

Study leader's telephone:

15923038767

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2503784659@qq.com

研究负责人电子邮件:

Study leader's E-mail:

cypgxhcj@tom.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

重庆市渝中区临江路76号

研究负责人通讯地址:

重庆市渝中区临江路76号

Applicant address:

76 Linjiang Road,Yuzhong District,Chongqing

Study leader's address:

76 Linjiang Road,Yuzhong District,Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

重庆医科大学附属第二医院麻醉科

Applicant's institution:

Department of Anesthesiology,The Second Affiliated Hospital of Chongqing Medical University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2021-61

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

重庆医科大学附属第二医院伦理委员会

Name of the ethic committee:

Ethics Committee of t he Second Affiliated Hospital of Chongqing Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2021-07-09 00:00:00

伦理委员会联系人:

王大刚

Contact Name of the ethic committee:

Dagang Wang

伦理委员会联系地址:

重庆市渝中区临江路76号

Contact Address of the ethic committee:

76 Linjiang Road,Yuzhong District,Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 23-63693014

伦理委员会联系人邮箱:

Contact email of the ethic committee:

kuanrenlunli@qq.com

研究实施负责(组长)单位:

重庆医科大学附属第二医院麻醉科

Primary sponsor:

Department of Anesthesiology,The Second Affiliated Hospital of Chongqing Medical University

研究实施负责(组长)单位地址:

重庆市渝中区临江路76号

Primary sponsor's address:

76 Linjiang Road,Yuzhong District,Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆

市(区县):

Country:

China

Province:

Chongqing

City:

单位(医院):

重庆医科大学附属第二医院

具体地址:

渝中区临江路76号

Institution
hospital:

The Second Affiliated Hospital of Chongqing Medical University

Address:

76 Linjiang Road, Yuzhong District

经费或物资来源:

自选课题

Source(s) of funding:

Optional subjects

Target disease:

anesthesia induction

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

横断面 

Study design:

Cross-sectional 

研究目的:

本研究是为了观察昼夜节律是否影响接受择期手术的健康成年人喉罩置入时的七氟醚MAC,并滴定出不同时间段成人半数喉罩置入肺泡气有效浓度(MAC LAM)而进行的一项研究,以明确七氟烷的药效时间节律性,从而对不同时间段使用七氟烷进行麻醉诱导喉罩置入提供参考浓度,提高患病者的舒适度,减少出现不良反应的几率。  

Objectives of Study:

The purpose of this study is to observe whether circadian rhythms affected sevoflurane MAC during laryngeal mask insertion in healthy adults undergoing elective surgery, and to titrate the effective concentration of alveolar gas (MAC LAM) for half laryngeal mask insertion in adults at different time periods, so as to determine the temporal rhythm of sevoflurane efficacy. Besides,we can provide reference concentration for anesthesia induced laryngeal mask insertion with sevoflurane in different time periods, improve the comfort level of patients with disease and reduce the probability of adverse reactions.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄30-65岁。2.行择期短小手术做全身麻醉的患者。3.ASAⅠ-Ⅱ级。4.自愿参加并签署了知情同意书。

Inclusion criteria

1. From 30 years old to 65 years old 2.Patients undergoing elective short surgery under general anesthesia 3. ASAI-II级 4. Willing to participate and able to understand and sign informed consent

排除标准:

1.术前肝、肾功能异常 2.既往有异常手术麻醉史 3.有氟烷类药物过敏史 4.有脊髓病变者 5.有恶性高热家族史 6.预计为困难气道 7.癫痫病史 8.肌营养不良症患者 9.饱胃反流误吸高风险患者 10.有喉罩使用禁忌症患者 11.孕妇或产妇 12.三个月内参加过其他药物试验

Exclusion criteria:

1.Abnormal liver and kidney function before surgery 2.Abnormal surgical anesthesia history 3.History of allergy to haloalkanes 4.Patients with myelopathy 5.Family history of malignant hyperthermia 6. Difficult airway 7.History of epilepsy 8.Patients with muscular dystrophy 9. Patients at high risk of emergency, satiety and reflux aspiration 11.Pregnant women and women in childbirth 12.Participated in other drug experiments within three months

研究实施时间:

Study execute time:

From 2021-07-20 00:00:00 To 2022-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2021-07-20 00:00:00 To 2022-06-30 00:00:00  

干预措施:

Interventions:

组别:

上午组1

样本量:

30

Group:

The morning group 1

Sample size:

干预措施:

3%七氟烷诱导麻醉

干预措施代码:

Intervention:

Anesthesia is induced with 3% sevoflurane

Intervention code:

组别:

下午组1

样本量:

30

Group:

The afternoon group 1

Sample size:

干预措施:

3%七氟烷诱导麻醉

干预措施代码:

Intervention:

Anesthesia is induced with 3% sevoflurane

Intervention code:

组别:

上午组2

样本量:

30

Group:

The morning group 2

Sample size:

干预措施:

滴定喉罩置入时七氟烷所需半数有效肺泡浓度

干预措施代码:

Intervention:

Titrate the half effective alveolar concentration of sevoflurane at laryngeal mask insertion

Intervention code:

组别:

下午组2

样本量:

30

Group:

The afternoon group 2

Sample size:

干预措施:

滴定喉罩置入时七氟烷所需半数有效肺泡浓度

干预措施代码:

Intervention:

Titrate the half effective alveolar concentration of sevoflurane at laryngeal mask insertion

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China 

Province:

Chongqing 

City:

 

单位(医院):

重庆医科大学附属第二医院 

单位级别:

三级甲等 

Institution
hospital:

The Second Affiliated Hospital of Chongqing Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

不同浓度七氟烷喉罩置入时反应

指标类型:

主要指标

Outcome:

Reactions of different concentrations sevoflurane for laryngeal mask insertion

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

心率

指标类型:

主要指标

Outcome:

Heart rate

Type:

Primary indicator

测量时间点:

喉罩置入前后

测量方法:

Measure time point of outcome:

Before and after laryngeal mask insertion

Measure method:

指标中文名:

血压

指标类型:

主要指标

Outcome:

Blood pressure

Type:

Primary indicator

测量时间点:

喉罩置入前后

测量方法:

Measure time point of outcome:

Before and after laryngeal mask insertion

Measure method:

指标中文名:

麻醉脑电监测指标

指标类型:

主要指标

Outcome:

EEG monitoring value

Type:

Primary indicator

测量时间点:

喉罩置入前后

测量方法:

Measure time point of outcome:

Before and after laryngeal mask insertion

Measure method:

指标中文名:

氧饱和度

指标类型:

次要指标

Outcome:

oxygen saturation

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

N/A

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 30 years
最大 Max age 65 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

本研究不涉及随机

Randomization Procedure (please state who generates the random number sequence and by what method):

No applicable

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

通过通讯作者邮箱

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Through the corresponding author email

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2021-07-19 23:51:59